CoChat

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

Open access

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal fibrosing lung disease of unknown cause. The advent of anti-fibrotic medications known to slow disease progression has revolutionised IPF management in recent years. However, little is known about the natural history of IPF patients with mild physiological impairment. We aimed to assess the natural history of these patients using data from the Australian IPF Registry (AIPFR). METHODS: Using our cohort of real-world IPF patients, we compared FVC criteria for mild physiological impairment (FVC ≥ 80%) against other proposed criteria: DLco ≥ 55%; CPI ≤40 and GAP stage 1 with regards agreement in classification and relationship with disease outcomes. Within the mild cohort (FVC ≥ 80%), we also explored markers associated with poorer prognosis at 12 months. RESULTS: Of the 416 AIPFR patients (mean age 70.4 years, 70% male), 216 (52%) were classified as 'mild' using FVC ≥ 80%. There was only modest agreement between FVC and DLco (k = 0.30), with better agreement with GAP (k = 0.50) and CPI (k = 0.48). Patients who were mild had longer survival, regardless of how mild physiologic impairment was defined. There was, however, no difference in the annual decline in FVC% predicted between mild and moderate-severe groups (for all proposed criteria). For patients with mild impairment (n = 216, FVC ≥ 80%), the strongest predictor of outcomes at 12 months was oxygen desaturation on a 6 min walk test. CONCLUSION: IPF patients with mild physiological impairment have better survival than patients with moderate-severe disease. Their overall rate of disease progression however, is comparable, suggesting that they are simply at different points in the natural history of IPF disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12890-018-0575-y

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Classification as mild disease using different mild definitions
Fig. 1 Classification as mild disease using different mild definitionsCC BY · PubMed Central
Fig. 2 Kaplan Meier analysis for time to death by disease category. a. Kaplan Meier analysis according to FVC 80%. Log rank test p < 0.001. b. Kaplan Meier analysis according to DLco 55%. Log rank test p < 0.001. c. Kaplan Meier analysis according to CPI 40. CPI (composite physiological index). Log rank test p < 0.001. d. Kaplan Meier analysis according to GAP stage. GAP (Gender, Age, Physiology). Log rank test p < 0.001
Fig. 2 Kaplan Meier analysis for time to death by disease category. a. Kaplan Meier analysis according to FVC 80%. Log rank test p < 0.001. b. Kaplan Meier analysis according to DLco 55%. Log rank test p < 0.001. c. Kaplan Meier analysis according to CPI 40. CPI (composite physiological index). Log rank test p < 0.001. d. Kaplan Meier analysis according to GAP stage. GAP (Gender, Age, Physiology). Log rank test p < 0.001CC BY · PubMed Central
Fig. 3 Decline in FVC % predicted in mild (FVC ≥ 80%) compared with moderate-severe (FVC < 80%) physiological impairment. Graphical representation of annual FVC% decline as calculated by unstructured linear mixed model with random intercept and slopes for mild and moderate-severe disease
Fig. 3 Decline in FVC % predicted in mild (FVC ≥ 80%) compared with moderate-severe (FVC < 80%) physiological impairment. Graphical representation of annual FVC% decline as calculated by unstructured linear mixed model with random intercept and slopes for mild and moderate-severe diseaseCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 84

Metadata

Authors
Jo, H. E., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Reynolds, P., Haydn Walters, E., Zappala, C., Grainge, C., Allan, H., Macansh, S., & Corte, T. J.
Affiliations
  • The University of Sydney (AU)
  • The Alfred Hospital (AU)
  • Fiona Stanley Hospital (AU)
  • Royal Adelaide Hospital (AU)
  • Austin Hospital (AU)
  • Prince Charles Hospital (AU)
  • Royal Prince Alfred Hospital (AU)
  • Royal Brisbane and Women's Hospital (AU)
  • John Hunter Hospital (AU)
  • Lung Foundation Australia (AU)
Corresponding author
Jo, Helen E.
Venue
BMC Pulmonary Medicine
Published
2018-01-25
Volume
18
Issue
1
Pages
19-19
ISSN
1471-2466 (ISSN-L)
OpenAlex
W2787279971
Cited by
77
References
22
Citations by year
2026: 3 · 2025: 8 · 2024: 4 · 2023: 8 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 14 · 2018: 3
FWCI
8.29
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Pulmonary Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UTAS Research Repository (acceptedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
National Health and Medical research Council (APP1066128)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
idiopathic pulmonary fibrosis, natural history (disease), disease progression, forced vital capacity, diffusing capacity for carbon monoxide, chronic respiratory failure, prognosis, survival, oxygen desaturation, 6-minute walk test, antifibrotic therapy
MeSH terms
Walk Test, Age Factors, Aged, Australia, Carbon Monoxide, Female, Humans, Male, Middle Aged, Oxygen, Pulmonary Diffusing Capacity, Registries, Severity of Illness Index, Sex Factors, Smoking, Vital Capacity, Body Mass Index, Disease Progression, Idiopathic Pulmonary Fibrosis, Symptom Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. https://app.cochat.ai/papers/10.1186/s12890-018-0575-y
The paper
Jo, H. E., Glaspole, I., Moodley, Y., Chapman, S., Ellis, S., Goh, N., Hopkins, P., Keir, G., Mahar, A., Cooper, W., Reynolds, P., Haydn Walters, E., Zappala, C., Grainge, C., Allan, H., Macansh, S., & Corte, T. J. (2018). Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-018-0575-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.